Non-Motor Symptom Scale | ||||||||||
‘Mild to moderate’ | ‘Severe’ | ‘Very severe’ | ||||||||
(≤40) | (41–70) | (≥71) | ||||||||
n | Mean | SD | n | Mean | SD | n | Mean | SD | P value | |
PDQ-8 Summary Index | 56 | 26.2 | 12.3 | 50 | 33.7 | 13.3 | 60 | 41.4 | 15.5 | <0.001*** |
Hoehn and Yahr Scale | ||||||||||
‘Minimal to mild’ | ‘Moderate’ | ‘Severe’ | ||||||||
(≤ 2.5) | (3) | (≥ 4) | ||||||||
n | Mean | SD | n | Mean | SD | n | Mean | SD | P value | |
PDQ-8 Summary Index | 96 | 31.3 | 14.5 | 48 | 37.2 | 14.7 | 19 | 37.3 | 16.7 | 0.105 |
Levodopa challenge test response | ||||||||||
‘Low’ | ‘Partial’ | ‘Full’ | ||||||||
(<33%) | (33%–50%) | (>50%) | ||||||||
n | Mean | SD | n | Mean | SD | n | Mean | SD | P value | |
PDQ-8 Summary Index | 43 | 34.2 | 14.1 | 55 | 34.1 | 15.5 | 66 | 33.7 | 15.8 | 0.947 |
Kruskal-Wallis tests were performed for independent samples for between-strata analyses of baseline parameters. Multiple comparisons (three strata) were corrected with the Bonferroni method.
Bold font highlights significant results.
***p<0.001.
PDQ-8, 8-item Parkinson’s Disease Questionnaire.